Cancer Archives

Colorectal cancer deaths are down in US

The American College of Gastroenterology is committed to national policy changes to improve access to colorectal screening and increased use of these proven prevention strategies. – New data revealing decreasing trends in cancer deaths in the United States overall, and in colorectal cancer deaths in particular, highlight the remarkable benefits of colorectal cancer screening tests, but the lifesaving potential of these tests is unrealized for many Americans, according to experts from the American College of Gastroenterology.

Managers less likely to suffer from cancers

Managers and administrators are less likely to suffer from cancers according to a University of Sydney study published in the latest Medical Journal of Australia. – Managers and administrators are less likely to suffer from cancers, possibly because they are less exposed to risk factors or because they can more easily afford to retire when their health deteriorates.

Uninsured diagnosed with an advanced stage cancer

Uninsured or Medicaid-insured patients are far more likely to be diagnosed with an advanced stage cancer than those with private insurance, according to a new American Cancer Society study of 3.5 million cancer patients with 12 of the most common cancer types. – A new American Cancer Society study of twelve types of cancer among more than 3.5 million cancer patients finds uninsured patients were significantly more likely to present with advanced stage cancer compared to patients with private insurance.

Heavy cell phone users subject to cancers

Cell Phone – Cancer Link Found by Tel Aviv University Scientist; A new study finds an association between heavy cell phone use and tumors – An Israeli scientist, Dr. Siegal Sadetzki, has found a link between cell phone usage and the development of tumors. Dr. Sadetzki, a physician, epidemiologist and lecturer at Tel Aviv University, published the results of a study recently in the American Journal of Epidemiology, in which she and her colleagues found that heavy cell phone users were subject to a higher risk of benign and malignant tumors of the salivary gland.

Zydus Cadila introduces Nudoxa cancer drug

Zydus Cadila has introduced Nudoxa for the treatment of various cancers. One of the critical drugs used in chemotherapy, Nudoxa heralds a new approach in cancer therapy. – Zydus Cadila has introduced an NDDS product ‘Nudoxa’ for the treatment of various cancers. One of the critical drugs used in chemotherapy, Nudoxa heralds a new approach in cancer therapy.

Avastin found effective in advanced breast cancer patients

Avado Study of Avastin Plus Docetaxel Chemotherapy Showed Improved Progression-Free Survival in Patients With Advanced Breast Cancer – Genentech, Inc. (NYSE: DNA) announced that AVADO, a Roche-sponsored Phase III, placebo-controlled study evaluating Avastin? (bevacizumab) in combination with docetaxel chemotherapy met its primary endpoint of prolonging progression-free survival (PFS) in patients who had not received prior chemotherapy for their locally recurrent or metastatic HER2-negative breast cancer.

Breast cancer sufferers demand answers from PHARMAC, New Zealand

Herceptin Heroines are back in the High Court today to continue their case against drug funding agency PHARMAC, New Zealand. – 8 cancer survivors are in the New Zealand High Court to fight their case against drug funding agency PHARMAC. The women are challenging PHARMAC’s decision not to fund 12 months of Herceptin treatment for NZ women with HER2 positive breast cancer.

1 in 20 breast cancer web pages features inaccuracies

Review of online breast cancer information encourages healthy skepticism for consumers; Quality criteria does not determine accuracy of web site. Web site quality criteria failed to detect online health information errors during a study by UT researchers Elmer Bernstam, M.D., and his wife, Funda Meric-Bernstam, M.D. – In an extended analysis of Web pages dedicated to disseminating breast cancer information, researchers at two University of Texas institutions in Houston have determined that while most breast cancer data found online was accurate, one in 20 breast cancer Web pages featured inaccuracies and sites displaying complementary and alternative medicine were 15 times more likely to contain false or misleading health information.

7 new prostate cancer genetic risk factors identified

UK researchers identified more than 7 new genetic links to prostate cancer, 2 of which would be included in a new diagnostic test aimed at spotting men at risk from this disease. – 7 new sites in the human genome identified that are linked to men’s risk of developing prostate cancer, revealed by Cancer Research UK funded scientists at the Institute of Cancer Research and University of Cambridge.

IGFBP7 protein may stop melanoma skin cancer

One might call it a tale of two melanocytes. Given the same genetic mutation, why does one melanocyte shut down growth and become a relatively benign mole, while another rages out of control and develops into deadly melanoma” – Howard Hughes Medical Institute (HHMI) researchers have uncovered a protein that stops the growth of melanoma, a cancer that develops from pigment-producing cells in the skin called melanocytes.

$9 million grant for prostate cancer research

$9 million grant from the National Cancer Institute (NCI) awarded to Henry Ford to study the effectiveness of gene therapy to treat prostate cancer. – Henry Ford Hospital is embarking on an expanded major clinical trial involving the use of gene therapy in combination with radiation therapy, to determine if the combined treatment is more effective than radiation therapy alone for patients with intermediate risk prostate cancer.

Occupational cancer risk in fruit and veg growers, hairdressers

New research by staff at the University’s Centre for Public Health Research show occupational cancer risk in fruit and veg growers, hairdressers and sewing machinists. – Increased risk of cancer for occupational groups including hairdressers, sewing machinists, field crop and fruit and vegetable growers, reported by New Zealand researchers. Occupational cancers account for 330 deaths in New Zealand each year, about five per cent.